These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1926039)

  • 1. Role of thrombin in arterial thrombosis: implications for therapy.
    Chesebro JH; Zoldhelyi P; Badimon L; Fuster V
    Thromb Haemost; 1991 Jul; 66(1):1-5. PubMed ID: 1926039
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombin inhibition and coronary artery thrombolysis.
    Yao SK; McNatt JM; Anderson HV; Eidt JF; Cui KX; Golino P; Glas-Greenwalt P; Maraganore JM; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1990; 103():1-9. PubMed ID: 2132522
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombin plays a pivotal role in vascular re-occlusion after PTCA and coronary thrombolysis.
    Agnelli G
    Cardiovasc Res; 1996 Feb; 31(2):232-4. PubMed ID: 8730398
    [No Abstract]   [Full Text] [Related]  

  • 4. [Left ventricular thrombosis after acute myocardial infarction: relationship with thrombolytic therapy and the patency of the "guilty" vessel].
    Pizzetti G; Belotti G; Chierchia SL
    G Ital Cardiol; 1994 Mar; 24(3):253-60. PubMed ID: 8063060
    [No Abstract]   [Full Text] [Related]  

  • 5. Hirudin in the treatment of arterial and venous thrombotic diseases: a new perspective.
    Büller HR
    Z Kardiol; 1993; 82 Suppl 2():81-2. PubMed ID: 8328213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of intra-coronary thrombosis in the anaesthetised dog: the importance of thromboxane A2 and thrombin.
    White BP; Sullivan AT; Lumley P
    Thromb Haemost; 1994 Mar; 71(3):366-74. PubMed ID: 8029802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving concepts in the pathogenesis and treatment of arterial thrombosis.
    Chesebro JH; Toschi V; Lettino M; Gallo R; Badimon JJ; Fallon JT; Fuster V
    Mt Sinai J Med; 1995 Sep; 62(4):275-86. PubMed ID: 7565850
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Direct thrombin inhibitors: their role in the treatment of arterial and venous thrombosis].
    Rocha E; Panizo C; Lecumberri R
    Med Clin (Barc); 2001 Jan; 116(2):63-74. PubMed ID: 11181274
    [No Abstract]   [Full Text] [Related]  

  • 10. [The endothelium and antithrombotic substances].
    Eber B
    Acta Med Austriaca; 1989; 16(5):102-4. PubMed ID: 2698051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The direct thrombin inhibitor hirudin.
    Greinacher A; Warkentin TE
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of thrombin and its inhibition in unstable angina. Nonfractionated heparin, hirudin and defractionated heparins].
    López-Sendón J; López de Sá E; Rubio Sanz R; Delcán Domínguez JL
    Rev Esp Cardiol; 1999; 52 Suppl 1():76-89. PubMed ID: 10364817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New aspects of blood coagulation inhibitory therapy within the scope of percutaneous transluminal coronary angioplasty (PTCA)].
    Schächinger V; Zeiher AM
    Z Kardiol; 1995 Sep; 84(9):651-67. PubMed ID: 8525667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the problem of the thrombolytic effect of heparin and nicotinic acid].
    Rasche H; Hiemeyer V
    Med Klin; 1968 Jan; 63(2):63-5. PubMed ID: 4175296
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of early reocclusion after thrombolysis of copper coil-induced thrombi in the canine carotid artery: comparison of PEG-hirudin and unfractionated heparin.
    Rübsamen K; Hornberger W
    Thromb Haemost; 1996 Jul; 76(1):105-10. PubMed ID: 8819261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy.
    Collen D
    Thromb Haemost; 1997 Jul; 78(1):742-6. PubMed ID: 9198249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective thrombin inhibitors: the next generation of anticoagulants.
    Deutsch E; Rao AK; Colman RW
    J Am Coll Cardiol; 1993 Oct; 22(4):1089-92. PubMed ID: 8409045
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombin, thrombin inhibitors, and the arterial thrombotic process.
    Maraganore JM
    Thromb Haemost; 1993 Jul; 70(1):208-11. PubMed ID: 8236106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.